Korean journal of dermatology (대한피부과학회지)

Korean Dermatological Association (대한피부과학회)
권호 표지

Clinicopathologic Analysis of Malignant Melanoma

최근 12년간 악성 흑색종의 임상 및 병리조직학적 연구

Lee, Dong Hoon;Kim, You Chan;Cho, Sang-Ho;Lee, Min-Geol
이동훈;김유찬;조상호;이민걸

  • Published : 20020800
⟨ Previous Next ⟩

Abstract

Background: Cutaneous melanoma is the leading fatal illness arising in the skin. The clinical and pathological characteristics of malignant melanoma are quite different among races and countries. Objective: The purpose of this study was to investigate the clinicopathologic behavior of malignant melanoma in Korea and define prognostic predictors. Methods: From the 61 patients diagnosed with malignant melanoma at the Department of Dermatology of the Severance Hospital, Yonsei University College of Medicine over a 12 year period(1989-2001), we analyzed mean age at onset, gender, histologic subtypes, tumor thickness, primary tumor locations, and metastatic sites. Univariate analysis and multivariate analyses for survival, according to clinical and histologic tumor behavior, were performed by means of Cox proportional hazard model. Survival curves were plotted by Kaplan-Meier method. Results: Fifty-eight primary cutaneous melanomas were identified and analyzed by both clinical behavior and histology. 1. The incidence of malignant melanoma has been rising at a fast rate in the Department of Dermatology, Yonsei University College of Medicine. 2. The male to female ratio was 1:1. Acral lentiginous melanoma was the most common type(56.9%) followed by nodular melanoma(19.0%), superficial spreading melanoma(12.1%), lentigo maligna melanoma(6.9%), and mucosal melanoma(5.1%) in this study. ALM(59 years) and SSM(53 years) developed in elderly persons, while NM(43 years) developed in younger persons. 3. Sole and nail bed were the favored sites in ALM. Trunk was the favored site in SSM. 4. Univariate and multivariate analyses for overall survival of melanoma revealed that male gender, lentigo maligna melanoma, thicker tumor(${\geq}4.0mm$), advanced stage(III and IV) have the tendency to poorer prognosis with significant differences. Conclusion: Our study revealed acral lentiginous melanoma was the most predominant type of melanoma in Korea, which is similar result to other Asian countries'. No similar large series has been conducted to assess the prognostic factors of melanoma in Korea. Therefore, we propose that gender, histologic subtypes, tumor thickness, stages are the independent risk factors for poor prognosis. Further prospective studies are needed to assess the biologic behavior of malignant melanoma of which the incidence has been increasing in Korea.

Keywords

References

  1. Landis SH, Murray T. Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin 1998;48:6-29 https://doi.org/10.3322/canjclin.48.1.6
  2. Balch CM, Milton GW, Shaw HM. Cutaneous Melanoma: Clinical management and treatment results worldwide. Philadelphia, JB Lippincott, 1985;13-506
  3. 김수남, 전수일, 순숙자, 조백기, 김종민, 김낙인등. 한국인의 악성 흑색종에 관한 관찰. 대한피부과학회 제38차 추계학술대회 초록집 1986;29-30
  4. 김우호, 박성희, 이현순. 점막에 발생한 악성 혹색종 27예의 병리학적 관찰. 대한암학회지 1986;18:177-182
  5. 조광현, 조이경, 이유신, 함의근. 선단흑색종의 임상 및 병리조직학적 고찰. 대피지 1989;27:388-394
  6. 원영호, 허수경, 이승철, 전인기, 김영표. 최근 10년간 악성 흑색종의 임상 및 병리조직학적 연구. 대피지 1991;29:193-202
  7. Elder D. Elenitsas R, Jaworsky C, Johnson B. Lever's histopathology of the skin. 8th eds. Philadelphia:Lippincott-Raven, 1997:625-684
  8. McGovern VJ, Mihm MC Jr, Bailly C, Booth JC, Clark WH Jr, Cochran AJ, et al. The classification of malignant melanoma and its histologic reporting. Cancer 1973; 32:1446-1455 https://doi.org/10.1002/1097-0142(197312)32:6<1446::AID-CNCR2820320623>3.0.CO;2-8
  9. Lever WF. Schamburg-Lever G. Histopathology of the Skin. Philadelphia, JB Lippincott, 1990;780-805
  10. Koh HK, Bhawan J. Tumors of the skin. In: Moschella SL. Hurley HJ, eds. Dermatology. 3rd ed. Philadelphia: W. B Saunders, 1992;1721-1808
  11. 송계용, 정경천, 조광현, 지제근, 함의근. 악성 흑색종의 입상 및 병리조직학적 고찰:104 증례 검색. 대한병리학회지 1997;31:566-573
  12. 장경애, 김종혁, 최지호, 성경제, 문기찬, 고재경. 악성 흑색종의 임상 및 병리조직학적 고찰. 대피지 2000;38:1435-1443
  13. Lin CS, Wang WJ, Wong CK. Acral melanoma: a clinicopathologic study of 28 patients. Int J Dermatol 1990;29:107-12 https://doi.org/10.1111/j.1365-4362.1990.tb04079.x
  14. Yoshie K, Kazuyuki I, Naoya Y, Kiyoshi H. Clinical and pathologic features of cutaneous malignant melanom a : a retrospective analysis of 124 Japanese patients. Jpn J Clin Oncol 1996;26:144-51 https://doi.org/10.1093/oxfordjournals.jjco.a023198
  15. Collins RJ: Melanoma in the Chinese of· Hongkong, Emphasis on volar and subungal sites. Cancer 1984;54;1482-1488 https://doi.org/10.1002/1097-0142(19841001)54:7<1482::AID-CNCR2820540745>3.0.CO;2-O
  16. Irwin M. Freedberg, Arthur Z. Eisen, Klaus Wolff, K. Frank Austen, Lowell A. Goldsmith, Stephen I. Katz, Thomas B. Fitzpatric k. Fitzpatrick's dermatology in general medicine. 5th ed. New York: McGraw-Hill, 1030-1116
  17. Balch CM, Houghton AN. Diagnosis of metastatic melanoma at distant sites. In: Balch CM, CM, Houghton AN, Milton GW, Sober AJ, Soong S, eds. Cutaneous melannoma, 2nd ed. Philadelphia;JB Lippincott, 1992;439-467
  18. Silver HK, Karim KA, Le-Riche-J. Nuclear DNA, serum sialic acid and measured depth in malignant melanoma for predicting disease recurrence and survival. Int J Cancer 1989;44:31-34 https://doi.org/10.1002/ijc.2910440106
  19. Kheir SM, Bines SD, Vonroenn JH. Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma. Ann Surg· 1988;207:455-461 https://doi.org/10.1097/00000658-198804000-00014
  20. Sober AJ, Day CI. Jr, Fitzpatrick TB. Factors associated with death from melanoma from 2 to 5 years following diagnosis in clinical stage I patients. J Invest Dermatol 1983;80:53s-55s https://doi.org/10.1111/1523-1747.ep12537168
  21. Kopf AW, Gross DF, Rogers GS. Prognostic index for malignant melanoma. Cancer 1987;59:1238-1241
  22. Huvos AG, Shah JP, Mike V. Prognostic factors in cutaneous malignant melanoma. Hum Pathol 1974;5:347-357 https://doi.org/10.1016/S0046-8177(74)80117-6
  23. Shaw HM, McGovern VJ, Milton GW. Malignant melanoma : influence of site lesion and age of patient in the female superiority in survival. Cancer 1980;46:2731-2735 https://doi.org/10.1002/1097-0142(19801215)46:12<2731::AID-CNCR2820461232>3.0.CO;2-2
  24. Koh UK, Michalik E, Sober AJ. Lentigo maligna melanoma has no better prognosis than other type of melanoma. J Clin Oncol 1984;2:994-1001 https://doi.org/10.1200/JCO.1984.2.9.994
  25. Weissmann A, Rosis DF, Harris MN. Prediction of lymph node metastases from the histologic feature of primary cutaneous malignant melanoma. Am J Dermatopathol 1984;6:35s https://doi.org/10.1097/00000372-198402000-00009
  26. Krementz ET, Feed RJ, Coleman WP III, Sutherland CM, Carter RD, Campbell M. Acral lentiginous melanoma: a clinical pathological entity. Ann Surg 1982;195:632-45 https://doi.org/10.1097/00000658-198205000-00013
  27. Calvin AR, Tina JH, Salve GR. Acral lentiginous melanoma. Arch Surg 1995;130:88-92 https://doi.org/10.1001/archsurg.1995.01430010090019
  28. Yi-Ju Chen, Chun-Ying Wu, Jung-Ta Chen, Jui-Lung Shen, Chien-Chou Chen, Hsi-Ching Wang. Clinicopathologic analysis of malignant melanoma in Taiwan. J Am Acad Dermatol 1999;41 :945-9 https://doi.org/10.1016/S0190-9622(99)70251-3
  29. Balch CM, Soong SJ, Shaw HM, Urist MM, McCarthy WH. An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: Balch CM, editor. Cutaneous melanoma. 2nd ed. Philadelphia:JB Lippincott, 1992;165-87
  30. Morton DL, Dabtyan DG, Wanek LA, Foshang LJ, Cochran AJ. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness. Cancer 1993;71:3737-43 https://doi.org/10.1002/1097-0142(19930601)71:11<3737::AID-CNCR2820711143>3.0.CO;2-7
  31. Schuchtlilr L , SchultzDJ, Synnestvedt M, Trock BJ, Guerry D, Elder DE, et al. The Pigmented Lesion Group. A prognostic model for predicting lO-year survival with primary melanoma. Ann Intern Med 1996;125:369-75 https://doi.org/10.7326/0003-4819-125-5-199609010-00003